We are live on ! Find out more

1,993 hedge funds and large institutions have $110B invested in Merck in 2018 Q1 according to their latest regulatory filings, with 108 funds opening new positions, 835 increasing their positions, 825 reducing their positions, and 101 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% more call options, than puts

Call options by funds: $1.37B | Put options by funds: $1.14B

18% more funds holding in top 10

Funds holding in top 10: 7184 (+13)

7% more first-time investments, than exits

New positions opened: 108 | Existing positions closed: 101

1% more repeat investments, than reductions

Existing positions increased: 835 | Existing positions reduced: 825

0.52% more ownership

Funds ownership: 77.69%78.21% (+0.52%)

1% less funds holding

Funds holding: 2,0091,993 (-16)

4% less capital invested

Capital invested by funds: $114B → $110B (-$4.18B)

Holders
1,993
Holders Change
-16
Holders Change %
-0.8%
% of All Funds
45.67%
Holding in Top 10
84
Holding in Top 10 Change
+13
Holding in Top 10 Change %
+18.31%
% of All Funds
1.92%
New
108
Increased
835
Reduced
825
Closed
101
Calls
$1.37B
Puts
$1.14B
Net Calls
+$227M
Net Calls Change
+$346M
Name Holding Trade Value Shares
Change
Change in
Stake
TSW
601
Thompson Siegel & Walmsley
Virginia
$5.53M -$607K -11,235 -10%
SFS
602
Strategic Financial Services
New York
$5.53M +$1.73M +32,093 +43%
RIA
603
RPG Investment Advisory
California
$5.53M +$584K +10,820 +11%
DY
604
Dowling & Yahnke
California
$5.49M -$69.7K -1,290 -1%
CC
605
Capital Counsel
New York
$5.48M -$42.7K -791 -0.7%
CB
606
Community Bank
New York
$5.48M +$8.37K +155 +0.1%
CI
607
Cigna Investments
Connecticut
$5.45M -$49.2K -911 -0.9%
GCM
608
Gabalex Capital Management
New York
$5.45M
PVI
609
Pura Vida Investments
New York
$5.45M +$5.66M +104,800 New
ECM
610
ETrade Capital Management
Virginia
$5.44M +$419K +7,759 +8%
MCTIC
611
MacGuire Cheswick & Tuttle Investment Counsel
Connecticut
$5.43M -$14.2K -262 -0.3%
BAS
612
Brown Advisory Securities
Maryland
$5.37M +$359K +6,645 +7%
PCM
613
Parsons Capital Management
Rhode Island
$5.36M -$43.4K -804 -0.8%
Walleye Trading
614
Walleye Trading
New York
$5.36M +$4.16M +77,076 +295%
BG
615
Bollard Group
Massachusetts
$5.36M +$384K +7,119 +7%
OIM
616
Opus Investment Management
Massachusetts
$5.36M
GA
617
GFS Advisors
Texas
$5.35M +$135K +2,508 +2%
SWM
618
SVA Wealth Management
Wisconsin
$5.35M +$363K +6,719 +8%
MI
619
Markston International
New York
$5.34M -$371K -6,870 -6%
PPSG
620
Princeton Portfolio Strategies Group
New Jersey
$5.33M -$271K -5,027 -5%
TCOV
621
Trust Company of Vermont
Vermont
$5.33M +$314K +5,805 +6%
BHA
622
Beech Hill Advisors
New York
$5.32M +$275K +5,094 +5%
AAM
623
Augustine Asset Management
Florida
$5.3M +$1.07M +19,878 +24%
BCM
624
Beddow Capital Management
Wyoming
$5.27M +$13K +241 +0.2%
BIA
625
Barry Investment Advisors
Massachusetts
$5.26M +$14.1K +261 +0.3%

MRK Hedge Fund Activity: Q1 2018 in Review

1,993 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q1 2018, worth a combined $110B — down 3.7% from $114B a quarter earlier.

Buyers outnumbered sellers: 108 funds opened new MRK positions and 101 closed out — a net gain of 7 holders — while 835 added to existing stakes and 825 trimmed.

The largest buyer was Bank of America, adding an estimated $720M. The largest seller was Wellington Management Group, cutting an estimated $1.02B.

  • 1,993 institutional investors held Merck (MRK) as of Q1 2018, down from 2,009 in Q4 2017.
  • Funds reported $110B of Merck stock for Q1 2018, down 3.7% quarter-over-quarter.
  • 108 funds opened new Merck positions in Q1 2018 and 101 closed out, a net change of +7 holders.
  • The largest Merck buyer in Q1 2018 was Bank of America, an estimated $720M added.
  • The largest Merck seller in Q1 2018 was Wellington Management Group, an estimated $1.02B sold.

Based on aggregated 13F filings for Q1 2018.